Home> Products> motor symptoms

{ "products": [ { "_id": "68949d4ea0059029dc8c8915", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BENZTETRA 25", "description": "BENZTETRA 25 contains the active ingredient tetrabenazine 25mg, a specialized medication used primarily to manage involuntary movements associated with neurological disorders. Tetrabenazine is classified as a vesicular monoamine transporter 2 (VMAT2) inhibitor and works by regulating the levels of neurotransmitters such as dopamine, serotonin, norepinephrine, and histamine in the brain. This correction of chemical imbalances helps reduce excessive and uncontrolled muscle movements. BENZTETRA 25 is especially valuable for patients suffering from movement disorders that significantly impact their daily functioning. It helps improve motor control, thereby enhancing quality of life for those affected. This medication is prescribed mainly to treat chorea—a movement disorder characterized by jerky, irregular, and uncontrollable muscle movements—that is caused by Huntington disease.\n\nWhat is BENZTETRA 25?\nBENZTETRA 25 is a therapeutic tablet containing tetrabenazine 25mg, designed to treat involuntary movements (chorea) linked to Huntington disease. It does not cure Huntington disease nor address cognitive or psychiatric symptoms of the disease but effectively reduces the severity of abnormal movements by altering neurotransmitter activity in the brain.\n\nUses of BENZTETRA 25\n\nTo treat chorea (a movement disorder) that is caused by Huntington disease.\n\nTo control involuntary muscle movements in Huntington’s disease patients.\n\nManagement of other hyperkinetic movement disorders as determined by a healthcare provider (such as tardive dyskinesia or Tourette syndrome in some cases).\n\nTo reduce excessive motor activity caused by abnormal nerve signaling in the brain, improving voluntary muscle control.\n\nSide Effects of BENZTETRA 25\n\nDrowsiness and fatigue, which may affect alertness.\n\nInsomnia or difficulty sleeping.\n\nNausea, vomiting, or abdominal discomfort.\n\nParkinsonism symptoms such as tremors, muscle rigidity, and slowed movements (bradykinesia).\n\nMood alterations including depression, anxiety, and in severe cases, suicidal thoughts.\n\nRare serious reactions like allergic responses, heart rhythm irregularities, or neuroleptic malignant syndrome (characterized by high fever, muscle stiffness).\n\nPrecautions Before Using BENZTETRA 25\n\nInform your doctor if you have a history of depression, suicidal thoughts, or any psychiatric illness.\n\nAvoid use if you have severe liver disease or have recently taken monoamine oxidase inhibitors (MAOIs).\n\nCaution in patients with cardiac issues due to potential QT interval prolongation.\n\nUse with care when driving or operating machinery as BENZTETRA 25 may cause dizziness or drowsiness.\n\nDo not stop the medication suddenly without consulting your healthcare provider, as symptoms might worsen.\n\nRegular monitoring by a healthcare professional is recommended to assess side effects and efficacy.\n\nDrug Interactions: What Drugs Interact with BENZTETRA 25?\n\nMAO inhibitors such as isocarboxazid, phenelzine, selegiline, and others can cause dangerous interactions and should not be used concurrently.\n\nOther drugs that affect serotonin levels, including selective serotonin reuptake inhibitors (SSRIs), may increase the risk of serotonin syndrome.\n\nCaution with other medications known to prolong the QT interval or those affecting dopamine systems.\n\nInteractions with neuroleptics or antipsychotics require close medical supervision due to additive effects on movement and mood.\n\nConclusion\nBENZTETRA 25, containing tetrabenazine 25mg, is a vital medication for managing chorea associated with Huntington disease by modulating neurotransmitter levels in the brain to reduce involuntary movements. While it offers substantial benefits in improving motor control, careful attention to side effects, precautions, and drug interactions is essential for safe and effective use. Always follow the guidance of a healthcare professional when using BENZTETRA 25 to ensure optimal outcomes and safety.", "price": 425.0, "discountamount": 128.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2158, "imageuri": "https://productimages.withfloats.com/actual/68949d54c82f93461bdc841f.png", "tileimageuri": "https://productimages.withfloats.com/tile/68949d54c82f93461bdc841f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-07T12:34:22.411Z", "updatedon": "2025-08-07T12:34:22.411Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/benztetra-25/2158", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "tetrabenazine 25mg", "category": "NEUROLOGY RANGE", "tags": [ "tetrabenazine 25mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "686fb2fa7b16001ae8bc7d90", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIMAPEXOLE 0.25", "description": "PIMAPEXOLE 0.25 is a prescription medication that contains Pramipexole 0.25 mg, a dopamine agonist used for the treatment of Parkinson's disease and Restless Leg Syndrome (RLS). This medication works by stimulating dopamine receptors in the brain, helping to restore balance in motor function and reduce the symptoms associated with these neurological conditions.\n\nWhat is PIMAPEXOLE 0.25?\nPIMAPEXOLE 0.25 is a dopamine receptor stimulant that mimics the action of dopamine, a chemical messenger involved in movement and coordination. It is primarily used to relieve the motor symptoms of Parkinson’s disease such as tremors, stiffness, and slowness of movement. It is also effective in treating Restless Leg Syndrome by reducing the uncomfortable sensations and the irresistible urge to move the legs.\n\nUses of PIMAPEXOLE 0.25\nParkinson’s Disease: Helps reduce motor symptoms by compensating for the brain's reduced dopamine levels.\n\nRestless Leg Syndrome (RLS): Reduces discomfort and the need to move the legs, especially during periods of rest or sleep.\n\nHow PIMAPEXOLE 0.25 Works\nPramipexole acts by directly stimulating dopamine receptors in the brain, especially in areas responsible for body movement. Unlike levodopa, which gets converted into dopamine, pramipexole bypasses this process and directly activates the necessary receptors, offering sustained symptom control.\n\nSide Effects of PIMAPEXOLE 0.25\nCommon side effects may include:\n\nNausea\n\nDizziness\n\nFatigue\n\nInsomnia\n\nHallucinations\n\nLow blood pressure (especially when standing)\n\nSerious side effects may include compulsive behaviors, heart problems, and sudden sleep episodes. Report any unusual behavior or symptoms to your doctor promptly.\n\nPrecautions Before Using PIMAPEXOLE 0.25\nInform your doctor if you have heart disease, kidney problems, or mental health issues.\n\nAvoid driving or operating machinery if you feel drowsy.\n\nUse cautiously in elderly patients, as they may be more prone to hallucinations or confusion.\n\nLet your doctor know if you’re pregnant, planning to become pregnant, or breastfeeding.\n\nAvoid alcohol consumption while taking this medication, as it may increase drowsiness or dizziness.\n\nDrug Interactions: What Drugs Interact with PIMAPEXOLE 0.25?\nPIMAPEXOLE 0.25 can interact with several medications, such as:\n\nAntipsychotics (e.g., haloperidol, risperidone) – may reduce the effectiveness of pramipexole.\n\nSedatives or sleeping pills – may increase drowsiness.\n\nCimetidine – can increase pramipexole levels in the body.\n\nLevodopa or other dopaminergic drugs – may enhance the risk of side effects such as hallucinations or involuntary movements.\n\nAlways consult your healthcare provider before starting, stopping, or combining PIMAPEXOLE 0.25 with any other medication.\n\nConclusion\nPIMAPEXOLE 0.25 (Pramipexole 0.25 mg tablet) offers effective symptomatic relief for individuals suffering from Parkinson’s disease and Restless Leg Syndrome. Its targeted action on dopamine receptors helps manage symptoms and improve quality of life. Regular follow-ups and medical supervision are essential to ensure safety and optimal results.", "price": 65.0, "discountamount": 20.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2144, "imageuri": "https://productimages.withfloats.com/actual/686fb309d34d0d0ece846a89.png", "tileimageuri": "https://productimages.withfloats.com/tile/686fb309d34d0d0ece846a89.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-10T12:32:58.311Z", "updatedon": "2025-07-10T12:33:52.588Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pimapexole-0-25/2144", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "pramipexole 0.25 mg tablet", "category": "NEUROLOGY RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67fce015a321e45fb2fa1992", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "pimavanserin 34 mg", "description": "Pimavanserin 34 mg is formulated as PIMASERIN 34, an atypical antipsychotic used to manage hallucinationsand psychotic symptoms of Parkinson’s disease. PIMASERIN 34 does not pose the same risk of exagervated parkinonism as traditional antipsychotics and has low motor side effects, allowing for better patient care outcomes.\n\nKey Benefits:\n\nHelps manage hallucinations and delusions in people with Parkinson’s disease psychosis.\n\nPsychiatric symptoms are alleviated without aggravating motor symptoms.\n\nQuality of life and daily functioning improve in affected individuals.\n\nMotor control is preserved as PIMASERIN 34 does not act on dopaminergic receptors.\n\nEfficacy and tolerability have been demonstrated with long-term use.\n\nHow Does It Work:\n\nPimavanserin acts as a selective inverse agonist and antagonist of the 5-HT2A receptor, which is believed to be involved in the formation of hallucinations and delusions. Modulation of these receptors is critical for the management of psychosis without blocking dopamine pathways; hence controlling movement, which is vital in Parkinson’s disease, becomes possible.\n\nSteps for Using:\nFollow PIMASERIN 34 as directed by your healthcare provider.\nIt is often taken daily, once a day, with or without meals.\nTake this medication with a glass of water and do not crush the tablet.\nDo not alter the dosage or discontinue the medication without consulting a doctor.\n\nAdverse Effects:\nSide effects that may commonly occur: confusion, swelling in the legs or arms, constipation, and nausea.\nSome users may have difficulty sleeping or dizziness.\nWhile heart rhythm abnormalities are considered serious but rare side effects, they are still possible.\nIf you experience an unusual heartbeat, shortness of breath, or fainting, seek help immediately.\n", "price": 165.0, "discountamount": 50.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "pimaserin 34", "follow pimaserin 34", "delusions modulation", "fainting seek", "difficulty sleeping", "arms constipation", "healthcare provider", "parkinsons disease", "controlling movement", "5ht2a receptor", "traditional antipsychotics", "exagervated parkinonism", "atypical antipsychotic", "dopaminergic receptors efficacy", "daily functioning improve", "unusual heartbeat shortness", "rare side effects", "heart rhythm abnormalities", "blocking dopamine pathways", "selective inverse agonist", "work pimavanserin acts" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2080, "imageuri": "https://productimages.withfloats.com/actual/67fce0170f7652730cf4a74a.png", "tileimageuri": "https://productimages.withfloats.com/tile/67fce0170f7652730cf4a74a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-14T10:14:45.062Z", "updatedon": "2025-04-14T10:14:45.062Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pimavanserin-34-mg/2080", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIMASERIN 34", "category": "NEUROLOGY RANGE", "tags": [ "Pimavanserin brands in India", "Pimavanserin 34 mg capsule price", "Pimavanserin side effects", "Pimavanserin 34 mg uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be6b8aa93342004eef58f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 2 ", "description": "ROPINPRIME 2 \nRopinirole (2mg)\nIntroduction:\n\nRopinprime 2 is a medication containing Ropinirole, a potent dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 2mg, Ropinprime 2 is designed to effectively alleviate symptoms by mimicking dopamine's action in the brain, thus improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 2 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This action helps reduce motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 2 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 2 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 2mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 2 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 2 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 2 therapy to ensure therapeutic efficacy and patient safety.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-2-133629", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "RLS", "1mg", "8mg", "life", "aids", "food", "brain", "Order", "EMAIL", "0.5mg", "water", "0.25mg", "action", "nausea", "bedtime", "disease", "tremors", "patients", "Benefits", "condition", "Parkinson", "stiffness", "Ropinirole", "likelihood", "medication", "information", "Introduction", "bradykinesia", "independence", "tolerability", "initial dose", "sterisonline", "sterispharma", "greater ease", "Key Features", "CALL/WHATSAPP", "sleep quality", "starting dose", "motor symptoms", "patient safety", "multiple doses", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "patient response", "symptom severity", "daily activities", "clinical response", "Maintenance doses", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "2mg dosage strength", "Ropinprime 2 therapy", "healthcare providers", "therapeutic efficacy", "Continued Monitoring", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "uncomfortable sensations", "flexible dosing regimens", "individual patient needs", "Administration Instructions", "Swallow Ropinprime 2 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1895, "imageuri": "https://productimages.withfloats.com/actual/667d15dbce74849f89cdd68a.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d15dbce74849f89cdd68a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:44:08.261Z", "updatedon": "2024-06-27T07:33:46.566Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-2-/1895", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 2 ", "category": "NEUROLOGY RANGE", "tags": [ "Ropinirole (2mg)", "ROPINPRIME 2", "ropinirole side effects", "ropinirole side effects: weight gain", "ropinirole side effects in elderly" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be5a070774b1f84f699ad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 1 ", "description": "ROPINPRIME 1 \nRopinirole (1mg)\nIntroduction:\n\nRopinprime 1 contains Ropinirole, a potent dopamine agonist used primarily to treat Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 1mg, Ropinprime 1 is designed to alleviate symptoms by mimicking the action of dopamine in the brain, thereby improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 1 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This mechanism helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 1 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 1 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 1mg dosage strength provides flexibility in dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 1 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 1 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 1 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/ropinprime-1-133628", "price": 124.0, "discountamount": 37.2, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "day", "8mg", "life", "food", "EMAIL", "water", "0.5mg", "Order", "brain", "nausea", "action", "0.25mg", "bedtime", "disease", "tremors", "patients", "Benefits", "movement", "mechanism", "condition", "Parkinson", "stiffness", "medication", "likelihood", "Ropinirole", "flexibility", "information", "bradykinesia", "independence", "tolerability", "Introduction", "sterisonline", "initial dose", "sterispharma", "Key Features", "greater ease", "CALL/WHATSAPP", "starting dose", "sleep quality", "motor symptoms", "Initial Dosage", "multiple doses", "patient safety", "symptom control", "treatment plans", "dosing regimens", "Flexible Dosing", "overall comfort", "symptom severity", "patient response", "daily activities", "Maintenance doses", "clinical response", "dopamine receptors", "Regular monitoring", "1mg dosage strength", "uncontrollable urge", "Continued Monitoring", "therapeutic efficacy", "healthcare providers", "Ropinprime 1 therapy", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "Administration Instructions", "Swallow Ropinprime 1 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1894, "imageuri": "https://productimages.withfloats.com/actual/666be5a4475de163fe91643d.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be5a4475de163fe91643d.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:39:28.983Z", "updatedon": "2024-06-26T07:04:00.123Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-1-/1894", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 1 ", "category": "NEUROLOGY RANGE", "tags": [ "ROPINPRIME 1", "ropinirole side effects in elderly", "ropinirole side effects", "ropinirole warnings" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be4714cb45413344ec323", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 0.5 ", "description": "ROPINPRIME 0.5 \nRopinirole (0.5mg)\nIntroduction:\n\nRopinprime 0.5 contains Ropinirole, a dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 0.5mg, Ropinprime 0.5 aims to alleviate symptoms by mimicking the action of dopamine in the brain, thus improving motor function and enhancing quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 0.5 acts as a dopamine agonist, directly stimulating dopamine receptors in the brain. This action helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 0.5 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 0.5 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 0.5mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Ropinprime 0.5 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability.\nRestless Legs Syndrome:\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. Dosage may be adjusted according to patient response and symptom control.\nAdministration Instructions:\nSwallow Ropinprime 0.5 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 0.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-0-5-133627", "price": 60.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "aids", "life", "food", "Order", "water", "brain", "EMAIL", "0.25mg", "nausea", "action", "bedtime", "disease", "tremors", "patients", "Benefits", "stiffness", "condition", "Parkinson", "Ropinirole", "likelihood", "medication", "information", "Introduction", "initial dose", "independence", "greater ease", "tolerability", "Key Features", "sterispharma", "bradykinesia", "sterisonline", "CALL/WHATSAPP", "sleep quality", "starting dose", "patient safety", "motor symptoms", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "dopamine agonist", "patient response", "daily activities", "symptom severity", "clinical response", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "Continued Monitoring", "healthcare providers", "therapeutic efficacy", "0.5mg dosage strength", "dopaminergic activity", "Ropinprime 0.5 therapy", "overall motor function", "potential side effects", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "flexible dosing regimens", "Administration Instructions", "Restless Legs Syndrome Relief", "Swallow Ropinprime 0.5 tablets" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1893, "imageuri": "https://productimages.withfloats.com/actual/666be475844f2600246a0b63.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be475844f2600246a0b63.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:34:25.708Z", "updatedon": "2024-06-26T07:04:57.853Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-0-5-/1893", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "ropinprime 0.5 mg tablet 10", "ropinprime 0.5 mg tablet uses", "ropin 0.5 injection", "ropinirole warnings", "ropinirole side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ae69aaebebd0900165264", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RASAGAIL 1", "description": "RASAGAIL 1\nRasagail 1.0 \nIntroduction:\n\nRasagail 1.0 embodies the therapeutic efficacy of Rasagiline, a potent monoamine oxidase-B (MAO-B) inhibitor renowned for its role in managing Parkinson's disease. With a dosage strength of 1.0mg, Rasagail 1.0 offers a targeted approach to alleviate symptoms, enhance motor function, and potentially slow disease progression in Parkinson's patients.\nKey Features and Benefits:\n\nMAO-B Inhibition:\n\nRasagail 1.0 exerts its primary action by selectively inhibiting MAO-B enzymes, leading to increased dopamine levels within the brain's striatum. This mechanism aids in alleviating motor symptoms and improving overall motor function.\nNeuroprotection:\n\nBeyond symptom relief, Rasagail 1.0 demonstrates neuroprotective properties by reducing oxidative stress, preserving neuronal integrity, and potentially exerting disease-modifying effects in Parkinson's disease.\nImproved Motor Function:\n\nBy enhancing dopaminergic neurotransmission, Rasagail 1.0 contributes to smoother motor coordination, reduced rigidity, tremors, and bradykinesia, fostering greater mobility and functional independence.\nFlexible Dosing:\n\nRasagail 1.0 allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, disease severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Rasagail 1.0 is 1.0mg once daily, administered orally with or without food. Dosage adjustments may be considered based on individual patient response and tolerability.\nTitration and Maintenance:\nTitration of Rasagail 1.0 may occur under medical supervision to achieve optimal therapeutic benefits while minimizing adverse effects. Maintenance doses are typically adjusted as needed to sustain symptom control.\nContinued Monitoring:\nOngoing clinical monitoring of Parkinson's disease symptoms, motor function, and potential side effects is essential during Rasagail 1.0 therapy to ensure treatment efficacy and patient safety.For further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/rasagail-1-0-133623\n", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "role", "food", "brain", "1.0mg", "Order", "EMAIL", "tremors", "patients", "rigidity", "striatum", "Titration", "Parkinson", "mechanism", "Rasagiline", "information", "Introduction", "Key Features", "sterisonline", "sterispharma", "tolerability", "bradykinesia", "starting dose", "CALL/WHATSAPP", "MAO-B enzymes", "Initial Dosage", "Administration", "patient safety", "symptom relief", "motor symptoms", "primary action", "treatment plans", "adverse effects", "symptom control", "dosage strength", "Neuroprotection", "dopamine levels", "MAO-B Inhibition", "disease symptoms", "disease severity", "greater mobility", "oxidative stress", "MAO-B) inhibitor", "Maintenance doses", "targeted approach", "treatment efficacy", "neuronal integrity", "Dosage adjustments", "medical supervision", "disease progression", "healthcare providers", "Continued Monitoring", "therapeutic efficacy", "Rasagail 1.0 therapy", "potential side effects", "overall motor function", "functional independence", "Improved Motor Function", "individual patient needs", "flexible dosing regimens", "disease-modifying effects", "potent monoamine oxidase-B", "neuroprotective properties", "Ongoing clinical monitoring", "smoother motor coordination", "individual patient response", "optimal therapeutic benefits", "dopaminergic neurotransmission" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1888, "imageuri": "https://productimages.withfloats.com/actual/666ae69dc9162f54a1593ccc.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae69dc9162f54a1593ccc.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:31:22.172Z", "updatedon": "2024-06-26T07:19:57.74Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rasagail-1/1888", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RASAGAIL 1", "category": "NEUROLOGY RANGE", "tags": [ "RASAGAIL 1", "rasagiline 1 mg price", "rasagiline 1 mg uses", "rasagiline benefits", "rasagiline side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ae5c5ca84cd189c25cbff", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Rasagail 0.5 ", "description": "Rasagail 0.5 \nRasagiline (0.5mg)\nIntroduction:\n\nRasagail 0.5 encapsulates the medicinal prowess of Rasagiline, a potent and selective monoamine oxidase-B (MAO-B) inhibitor used in the management of Parkinson's disease. With a dosage strength of 0.5mg, Rasagail 0.5 aims to optimize neurological function and enhance quality of life for individuals battling Parkinson's disease.\nKey Features and Benefits:\n\nMAO-B Inhibition:\n\nRasagail 0.5 exerts its therapeutic effects by selectively inhibiting MAO-B enzymes, thereby increasing dopamine levels in the brain's striatum. This mechanism helps alleviate motor symptoms and improve motor function in Parkinson's disease.\nNeuroprotective Properties:\n\nBeyond symptomatic relief, Rasagail 0.5 offers neuroprotective benefits by reducing oxidative stress, preventing neuronal damage, and potentially slowing disease progression in Parkinson's patients.\nEnhanced Dopaminergic Transmission:\n\nBy enhancing dopaminergic neurotransmission, Rasagail 0.5 contributes to smoother motor coordination, reduced rigidity, tremors, and bradykinesia, fostering greater mobility and independence.\nAdjunctive Therapy:\n\nRasagail 0.5 can be used as monotherapy in early-stage Parkinson's disease or as an adjunct to levodopa/carbidopa in advanced stages, providing a comprehensive approach to symptom management.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Rasagail 0.5 is 0.5mg once daily, taken orally with or without food. Dosage adjustments may be made based on individual patient response and tolerability.\nTitration and Maintenance:\nGradual titration may occur as directed by healthcare providers to achieve optimal therapeutic benefits while minimizing side effects. Maintenance doses are typically tailored to individual patient needs.\nContinued Monitoring:\nRegular clinical assessments and monitoring of Parkinson's disease symptoms, motor function, and potential adverse effects are essential components of Rasagail 0.5 therapy to ensure treatment efficacy and safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/rasagail-0-5-133622", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "life", "EMAIL", "Order", "0.5mg", "brain", "safety", "tremors", "quality", "striatum", "rigidity", "patients", "carbidopa", "mechanism", "Rasagiline", "monotherapy", "information", "individuals", "Introduction", "sterisonline", "Key Features", "bradykinesia", "independence", "side effects", "tolerability", "sterispharma", "CALL/WHATSAPP", "MAO-B enzymes", "starting dose", "Administration", "Initial Dosage", "motor function", "motor symptoms", "dopamine levels", "dosage strength", "neuronal damage", "advanced stages", "MAO-B) inhibitor", "oxidative stress", "greater mobility", "MAO-B Inhibition", "disease symptoms", "Maintenance doses", "medicinal prowess", "Gradual titration", "Adjunctive Therapy", "symptom management", "Dosage adjustments", "treatment efficacy", "symptomatic relief", "therapeutic effects", "disease progression", "essential components", "healthcare providers", "Rasagail 0.5 therapy", "Continued Monitoring", "neurological function", "early-stage Parkinson", "comprehensive approach", "neuroprotective benefits", "individual patient needs", "potential adverse effects", "Neuroprotective Properties", "individual patient response", "smoother motor coordination", "optimal therapeutic benefits", "Regular clinical assessments", "selective monoamine oxidase-B", "dopaminergic neurotransmission", "Enhanced Dopaminergic Transmission" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1887, "imageuri": "https://productimages.withfloats.com/actual/666ae5c88c6c791fd3b65cab.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae5c88c6c791fd3b65cab.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:27:49.832Z", "updatedon": "2024-06-26T07:22:12.294Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//rasagail-0-5-/1887", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rasagail 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "rasagiline side effects", "rasagiline benefits", "long-term side effects of rasagiline", "rasagiline uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666ad72b56d62a1b8c8d620a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PRAMIXOLE 0.50 ", "description": "PRAMIXOLE 0.50 \nPramipexole (0.50mg)\nIntroduction:\n\nPRAMIXOLE 0.50 contains Pramipexole (0.50 mg), a dopamine agonist used to treat Parkinson’s disease and Restless Legs Syndrome (RLS). Pramipexole works by stimulating dopamine receptors in the brain, helping to improve movement control and alleviate symptoms associated with these conditions.\nKey Features and Benefits:\n\nParkinson’s Disease Management: Pramipexole is highly effective in managing symptoms of Parkinson’s disease, including tremors, stiffness, and slow movement, by enhancing the effects of dopamine.\nRestless Legs Syndrome Relief: It provides significant relief from the uncomfortable sensations and urge to move the legs, which are characteristic of Restless Legs Syndrome.\nImproved Motor Function: By stimulating dopamine receptors, Pramipexole improves motor function and coordination, enhancing the quality of life for patients with Parkinson’s disease.\nNeuroprotective Properties: Research suggests that Pramipexole may have neuroprotective effects, potentially slowing the progression of Parkinson’s disease.\nFlexible Dosing: The 0.50 mg dosage allows for precise adjustments based on individual needs and response to treatment.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of PRAMIXOLE 0.50 for Parkinson’s disease is 0.125 mg taken three times daily, gradually increased based on the patient's response to treatment. For Restless Legs Syndrome, the starting dose is usually 0.125 mg taken once daily, 2-3 hours before bedtime.\nMaintenance Dosage: The maintenance dose for Parkinson’s disease can range from 0.5 mg to 4.5 mg per day, divided into three doses. For RLS, the maintenance dose is typically 0.5 mg per day.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Pramipexole at the same time each day to maintain consistent medication levels in the bloodstream.\nMissed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not take a double dose to make up for a missed one.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/pramixole-0-50-133603", "price": 105.0, "discountamount": 31.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "day", "life", "food", "brain", "EMAIL", "Order", "water", "0.5 mg", "4.5 mg", "tablet", "tremors", "quality", "bedtime", "symptoms", "Benefits", "0.125 mg", "patients", "Research", "response", "Parkinson", "stiffness", "PRAMIXOLE", "same time", "next dose", "treatment", "conditions", "double dose", "three doses", "progression", "bloodstream", "information", "Pramipexole", "sterispharma", "coordination", "sterisonline", "Key Features", "Introduction", "CALL/WHATSAPP", "slow movement", "0.50 mg dosage", "Administration", "Initial Dosage", "Flexible Dosing", "dopamine agonist", "maintenance dose", "regular schedule", "individual needs", "movement control", "Disease Management", "significant relief", "Maintenance Dosage", "dopamine receptors", "precise adjustments", "typical starting dose", "neuroprotective effects", "Improved Motor Function", "uncomfortable sensations", "Neuroprotective Properties", "consistent medication levels", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1876, "imageuri": "https://productimages.withfloats.com/actual/666ad76c2d43284d727349be.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ad76c2d43284d727349be.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T11:25:31.913Z", "updatedon": "2024-06-26T07:45:10.553Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pramixole-0-50-/1876", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PRAMIXOLE 0.50 ", "category": "NEUROLOGY RANGE", "tags": [ "pramipexole 0.50 mg", "pramipexole 0.5 mg uses", "pramipexole long-term side effects", "pramipexole dosage", "pramipexole dosage for restless legs" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }